Remove 2001 Remove Animal Testing Remove Marketing
article thumbnail

Levers for Biological Progress

Codon

Though my focus in this essay is narrow — I don’t discuss bottlenecks in clinical trials, human disease, or animal testing — I hope others will take on these challenges in similar essays. This essay focuses on how we might do both, specifically for the cell. Subscribe to Asimov Press.

DNA 133
article thumbnail

Human neuronal cells: possibilities in drug safety testing

Drug Target Review

5,6 The range of CNS-related toxicities encountered throughout drug development and post-market approval is vast, and includes abuse liability, suicidal ideation, emesis, sleep disorder and cognitive dysfunction to name a few. 2001 Sep;24(9):517–26. The electrophysiological development of cardiomyocytes. Adv Drug Deliv Rev.

Drugs 111